Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands

[1]  David D. Kim,et al.  A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues , 2022, Value in Health.

[2]  J. Coast,et al.  The Children and Young People Quality of Life Study: A protocol for the qualitative development of attributes for capability wellbeing measures for use in health economic evaluation with children and young people , 2022, Wellcome Open Research.

[3]  M. Marle,et al.  The ICEpop Capability Measure for Adults Instrument for Capabilities: Development of a Tariff for the Dutch General Population. , 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  C. Groothuis-Oudshoorn,et al.  The ICECAP-A instrument for capabilities: assessment of construct validity and test–retest reliability in a general Dutch population , 2021, Quality of Life Research.

[5]  S. Walker,et al.  Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies , 2021, PharmacoEconomics.

[6]  P. Frijters,et al.  A Handbook for Wellbeing Policy-Making , 2021 .

[7]  T. Peters,et al.  Challenges in developing capability measures for children and young people for use in the economic evaluation of health and care interventions , 2021, Health economics.

[8]  Philip Kinghorn,et al.  Eliciting a monetary threshold for a year of sufficient capability to inform resource allocation decisions in public health and social care. , 2021, Social science & medicine.

[9]  David A. Drew,et al.  Attributes and predictors of long COVID , 2021, Nature Medicine.

[10]  S. Majumdar,et al.  A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker) , 2021, Nature Human Behaviour.

[11]  T. Blakely,et al.  Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases , 2020, BMJ.

[12]  Y. Teh,et al.  Inferring the effectiveness of government interventions against COVID-19 , 2020, Science.

[13]  R. Layard,et al.  Taking a wellbeing years approach to policy choice , 2020, BMJ.

[14]  S. Bhatt,et al.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.

[15]  Philip Kinghorn,et al.  A Systematic Review of the Feasibility and Psychometric Properties of the ICEpop CAPability Measure for Adults and Its Use So Far in Economic Evaluation. , 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[16]  Joanna Coast,et al.  Capability instruments in economic evaluations of health-related interventions: a comparative review of the literature , 2019, Quality of Life Research.

[17]  J. Richardson,et al.  Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities? , 2017, PharmacoEconomics.

[18]  W. Brouwer,et al.  From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare , 2016, PharmacoEconomics.

[19]  J. Richardson,et al.  The Relative Impacts of Disease on Health Status and Capability Wellbeing: A Multi-Country Study , 2015, PloS one.

[20]  J. Brazier,et al.  Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY , 2015, Applied Health Economics and Health Policy.

[21]  J. Coast,et al.  Assessing sufficient capability: A new approach to economic evaluation. , 2015, Social science & medicine.

[22]  Johnny Blair,et al.  Applied Survey Sampling , 2014 .

[23]  T. Peters,et al.  TEST–RETEST RELIABILITY OF CAPABILITY MEASUREMENT IN THE UK GENERAL POPULATION , 2014, Health economics.

[24]  J. Coast,et al.  A Qualitative Assessment of the Content Validity of the ICECAP-A and EQ-5D-5L and Their Appropriateness for Use in Health Research , 2013, PloS one.

[25]  T. Peters,et al.  Scoring the Icecap-A Capability Instrument. Estimation of a UK General Population Tariff† , 2013, Health economics.

[26]  T. Peters,et al.  An investigation of the construct validity of the ICECAP-A capability measure , 2012, Quality of Life Research.

[27]  S. Derrett,et al.  Retrospective evaluation versus population norms for the measurement of baseline health status , 2012, Health and Quality of Life Outcomes.

[28]  J. Coast,et al.  University of Birmingham Development of a self-report measure of capability wellbeing for adults: the ICECAP-A. , 2012 .

[29]  M. Weinstein,et al.  QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[30]  A. Sen,et al.  Inequality Re-examined , 1995 .

[31]  R. Sugden.  Commodities and Capabilities , 1986 .

[32]  J. Coast,et al.  The Children and Young People Quality of Life Study: A protocol for the qualitative development of attributes for capability wellbeing measures for use in health economic evaluation with children and young people [version 1; peer review: awaiting peer review] , 2022 .

[33]  M. Augustin,et al.  Measuring change in quality of life: bias in prospective and retrospective evaluation. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[35]  Manuela A. Joore,et al.  De ‘capability’-benadering: een nieuw perspectief op het meten van de kwaliteit van leven , 2015 .

[36]  T. Stockdale,et al.  Population estimates. , 2004, Health statistics quarterly.

[37]  A. Sen,et al.  Capability and Well-Being , 1991 .